PE0116 Injection in Treatment of Patients With Advanced Solid Tumours
Clinical trial NCT05800249 · COMPLETED
Trial details
- NCT number
- NCT05800249
- Sponsor
- Shanghai HyaMab Biotech Co.,Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-08
- Primary completion
- 2023-06-02
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.